Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Amortizatization of Intangibles for 3 consecutive years, with $717000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 132.04% to $717000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $879000.0, a 45.2% decrease, with the full-year FY2024 number at $1.3 million, down 58.51% from a year prior.
  • Amortizatization of Intangibles was $717000.0 for Q3 2025 at Whitehawk Therapeutics, up from -$2000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q1 2023 to a low of -$19000.0 in Q1 2025.
  • A 3-year average of $466636.4 and a median of $422000.0 in 2024 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 132.04% in 2025; the steepest drop was 104.5% in 2025.
  • Whitehawk Therapeutics' Amortizatization of Intangibles stood at $486000.0 in 2023, then plummeted by 62.35% to $183000.0 in 2024, then skyrocketed by 291.8% to $717000.0 in 2025.
  • Per Business Quant, the three most recent readings for WHWK's Amortizatization of Intangibles are $717000.0 (Q3 2025), -$2000.0 (Q2 2025), and -$19000.0 (Q1 2025).